ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0086

Geographic Distribution of Eosinophilic Fasciitis Cases in Massachusetts and Associated Environmental Triggers

Bina Kassamali1, Anastasiya Muntyanu2, Ruth Ann Vleugels3 and Avery LaChance3, 1Harvard Medical School, Brigham and Women's Hospital, Boston, MA, 2McGill University, Montreal, QC, Canada, 3Brigham and Women's Hospital, Boston, MA

Meeting: ACR Convergence 2020

Keywords: autoimmune diseases, Demographics, Environmental factors, Epidemiology

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Friday, November 6, 2020

Title: Miscellaneous Rheumatic & Inflammatory Diseases Poster I: Diagnosis and Testing

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Eosinophilic fasciitis (EF) is a rare fibrosing disorder of the fascia characterized by induration progressing proximally along the upper and lower extremities. Given the potential impact on joint mobility, EF can be associated with a high degree of morbidity and have a major impact on quality of life. To date, the etiologic trigger leading to disease onset remains unknown. Assessment of high incidence geographic clusters may be a crucial initial step to cause identification. ArcGIS is a geospatial processing program used to create and analyze geographic distributions and has recently been utilized to determine high incidence clusters for several cancers and autoimmune diseases. The purpose of this study is to determine the geographic distribution of eosinophilic fasciitis (EF) cases in Massachusetts and evaluate for possible environmental triggers.

Methods: The Research Patient Data Registry, which combines medical records from two large, academic tertiary care centers in Boston, was utilized to identify 294 potential cases of EF. Eighty-one of these were confirmed by board certified dermatologists or rheumatologists and were included in the study. Demographic and geographic data was extracted. EF cases were mapped by zip code using ArcMap 10.7.1. These maps were then compared to environmental exposure maps including those for industry and toxic waste sites, as well as to social justice maps.

Results: Elevated case counts of EF were observed in specific geographic regions in Massachusetts, including Revere, Charlestown, Westwood, North Andover, and Saugus. These regions were in proximity to landfills, chemical release sites, ash pollution, and combustion facilities (Figure 1). Based on social justice maps, EF cases were found to be more prevalent among low-income and minority communities (Figure 2). Review of medical records revealed that a high proportion of EF cases were smokers (49%) compared to the general population (~21% smokers). Of the patients with EF who underwent evaluation (n=40), 25% demonstrated a monoclonal gammopathy. Additionally, 26% of patients have a recorded past medical history of at least one more autoimmune disease in addition to EF.

Conclusion: To our knowledge, this is the first study to date assessing the geographic distribution of EF. The regional clustering of EF cases in proximity to ash, landfills, chemical release sites, and combustion facilities illustrates the potential contribution of environmental pollutants to the development of EF. Additional investigation using larger cohorts of patients with EF is warranted.

Figure 1. Locations of industries and waste sites in relation to EF case-counts

Figure 2. Social justice index and geographic distribution of EF cases


Disclosure: B. Kassamali, None; A. Muntyanu, None; R. Vleugels, None; A. LaChance, None.

To cite this abstract in AMA style:

Kassamali B, Muntyanu A, Vleugels R, LaChance A. Geographic Distribution of Eosinophilic Fasciitis Cases in Massachusetts and Associated Environmental Triggers [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/geographic-distribution-of-eosinophilic-fasciitis-cases-in-massachusetts-and-associated-environmental-triggers/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/geographic-distribution-of-eosinophilic-fasciitis-cases-in-massachusetts-and-associated-environmental-triggers/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology